Dmitriy Aleyev

affiliation not provided to SSRN

No Address Available

SCHOLARLY PAPERS

2

DOWNLOADS

1

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Sanofi-Aventis's Tender Offer for Genzyme

Darden Case No. UVA-F-1716
Number of pages: 24 Posted: 30 May 2017 Last Revised: 02 Jul 2018
Kenneth M. Eades, Pedro Matos and Dmitriy Aleyev
University of Virginia - Darden School of Business, University of Virginia - Darden School of Business and affiliation not provided to SSRN
Downloads 1 (656,915)
  • Add to Cart

Abstract:

Loading...

M&A, discounted cash flow valuation, biotechnology, pharma, pharmaceuticals, Sanofi, Sanofi-Aventis, Genzyme, tender offer, mergers and acquisitions, M & A, mergers & acquisitions, discounted cash flow, pharma, valuation

2.

The Sanofi-Aventis Acquisition of Genzyme: Contingent Value Rights

Darden Case No. UVA-F-1715
Number of pages: 16 Posted: 30 May 2017
Pedro Matos and Dmitriy Aleyev
University of Virginia - Darden School of Business and affiliation not provided to SSRN
Downloads 0 (674,275)
  • Add to Cart

Abstract:

Loading...

M&A valuation, market potential, biotechnology, estimates, contingent value right